EU's CHMP endorses H1N1 vaccines by Novartis and GSK
This article was originally published in Scrip
Executive Summary
The EU's CHMP has recommended two adjuvanted vaccines against pandemic H1N1, Novartis's Focetria and GlaxoSmithKline's Pandemrix, for approval.